Olayinka Rasheed Ibrahim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Olayinka Rasheed Ibrahim has a total of 260 co-authors. Here are the top co-authors by number of shared publications:
Amudalat Issa
Affiliation Department of Pediatrics, Children Specialist Hospital, Ilorin, Nigeria
12 shared publicationsMichael Abel Alao
Affiliation Department of Pediatrics, University College Hospital, Ibadan, Nigeria
9 shared publications- Michael Abel Alao
Department of Paediatrics, College of Medicine, University of Ibadan & University College Hospital, Ibadan, Nigeria
9 shared publications - Mohammed Baba Abdulkadir
Department of Paediatrics and Child Health University of Ilorin Teaching Hospital Ilorin Nigeria
7 shared publications Bello Mohammed Suleiman
Department of Paediatrics, Federal Teaching Hospital, Katsina, Katsina State, Nigeria
5 shared publicationsBiodun Sulyman Alabi
Department of ENT, University of Ilorin, Ilorin, Nigeria
4 shared publications
Latest Publications
- Open Access
Healthcare Providers’ Acceptability of Breast Milk Donation and Banking, and Factors Influencing Adoption in Rwanda: A Mixed-Methods Study
Breast milk is essential for optimal neonatal nutrition and survival, particularly among preterm and low-birth-weight infants. When a mother’s own milk is unavailable, donor breast milk is the recommended alternative. However, Rwanda currently lacks accredited breast milk donation systems and milk banks, and little is known about healthcare providers’ perspectives on their potential implementation. The main objective of the study was to assess the acceptability of breast milk donation and explore the potential factors that could influence its adoption among healthcare providers in two Rwandan district hospitals. A convergent parallel design with a qualitative-dominant approach was conducted in the neonatology units of Kirehe District Hospital and Ruhengeri Level-II Teaching Hospital, Rwanda. Quantitative data were collected from 41 healthcare providers using structured questionnaires, including a six-item Likert scale (0=strongly disagree to4=strongly agree) to measure acceptability. Scores≥2.4 were interpreted as indicating high acceptability. Qualitative data were obtained through in-depth interviews with 10 healthcare providers and analyzed using inductive thematic analysis. Quantitative data were analyzed using descriptive statistics and non-parametric tests. The overall acceptability of breast milk donation was high, with 82.9% of healthcare providers expressing agreement (mean score: 2.83±1.10). Most participants (97.6%) perceived donor breast milk as beneficial for neonatal health. Key barriers included cultural resistance, limited maternal awareness, and inadequate infrastructure, while facilitators were staff training, institutional policies, and community engagement. Qualitative findings highlighted that providers were generally familiar with the concept of breast milk donation but noted the absence of formal programs in Rwanda. They emphasized that cultural concerns often stem from limited knowledge rather than entrenched opposition and strongly endorsed the benefits for infant health and maternal wellbeing. Providers stressed that successful implementation would depend on awareness-raising, trust in safety procedures, and institutional support through training and clear guidelines. Breast milk donation is highly acceptable among healthcare providers in Rwanda, with a mean score of 2.83±1.10 on the 0–4 Likert scale. Providers strongly recognized its benefits for vulnerable infants. Addressing gaps in awareness, infrastructure, and policy frameworks, alongside culturally sensitive community education, will be critical for successful implementation. These findings support the feasibility of introducing breast milk banking in Rwanda and provide evidence to guide policy and program development.
Open AccessHealthcare Providers’ Acceptability of Breast Milk Donation and Banking, and Factors Influencing Adoption in Rwanda: A Mixed-Methods Study
Breast milk is essential for optimal neonatal nutrition and survival, particularly among preterm and low-birth-weight infants. When a mother’s own milk is unavailable, donor breast milk is the recommended alternative. However, Rwanda currently lacks accredited breast milk donation systems and milk banks, and little is known about healthcare providers’ perspectives on their potential implementation. The main objective of the study was to assess the acceptability of breast milk donation and explore the potential factors that could influence its adoption among healthcare providers in two Rwandan district hospitals. A convergent parallel design with a qualitative-dominant approach was conducted in the neonatology units of Kirehe District Hospital and Ruhengeri Level-II Teaching Hospital, Rwanda. Quantitative data were collected from 41 healthcare providers using structured questionnaires, including a six-item Likert scale (0=strongly disagree to4=strongly agree) to measure acceptability. Scores≥2.4 were interpreted as indicating high acceptability. Qualitative data were obtained through in-depth interviews with 10 healthcare providers and analyzed using inductive thematic analysis. Quantitative data were analyzed using descriptive statistics and non-parametric tests. The overall acceptability of breast milk donation was high, with 82.9% of healthcare providers expressing agreement (mean score: 2.83±1.10). Most participants (97.6%) perceived donor breast milk as beneficial for neonatal health. Key barriers included cultural resistance, limited maternal awareness, and inadequate infrastructure, while facilitators were staff training, institutional policies, and community engagement. Qualitative findings highlighted that providers were generally familiar with the concept of breast milk donation but noted the absence of formal programs in Rwanda. They emphasized that cultural concerns often stem from limited knowledge rather than entrenched opposition and strongly endorsed the benefits for infant health and maternal wellbeing. Providers stressed that successful implementation would depend on awareness-raising, trust in safety procedures, and institutional support through training and clear guidelines. Breast milk donation is highly acceptable among healthcare providers in Rwanda, with a mean score of 2.83±1.10 on the 0–4 Likert scale. Providers strongly recognized its benefits for vulnerable infants. Addressing gaps in awareness, infrastructure, and policy frameworks, alongside culturally sensitive community education, will be critical for successful implementation. These findings support the feasibility of introducing breast milk banking in Rwanda and provide evidence to guide policy and program development.
- Open Access
- 13 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0336091
Burden, risk factors, and clinical outcomes of pediatric malaria in Nigeria: A systematic review and meta-analysis protocol
Background: Nigeria ranks number one globally in malaria burden, with the exact burden, especially for hospitalization, unknown. This systematic review and meta-analysis will pool laboratory-confirmed pediatric malaria data across Nigeria using standardized World Health Organization (WHO) case definitions and random-effects modeling to generate precise national and subgroup-specific estimates of prevalence, associated factors, and outcomes, thereby addressing a critical evidence gap. Methods and analysis: A comprehensive search strategy using MeSH terms, text words, and entry terms will be applied across six databases: PubMed, Embase, EBSCOhost, Google Scholar, Web of Science, and Scopus. Eligible studies will be observational and interventional studies, without language restriction, from inception through June 30, 2025. Non-English studies will be translated using professional translation tools [Google Translate (academic mode) and Microsoft Translator] and verified by native speakers. The primary outcome is the pooled prevalence of pediatric malaria [overall, severe malaria vs. uncomplicated]. Secondary outcomes include factors influencing clinical presentation and outcomes, as well as the effects of moderators such as age, sex, socioeconomic status, and geographic location. Data extraction will capture study characteristics, participant demographics, and outcome measures. Methodological, clinical, and statistical heterogeneity will be assessed. Risk of bias will be assessed using the Newcastle-Ottawa Scale (NOS) adapted for observational studies, and the Cochrane Risk of Bias tool (RoB 2.0) for interventional studies. Publication bias will be examined using funnel plots and Egger’s regression. Pooled estimates will be reported with 95% confidence intervals. This will summarize the data on pediatric malaria in Nigeria. Using the random-effects models, the pooled prevalence, along with the 95% CI and the I 2 for the test of heterogeneity, will be reported. We will report the meta-regression analysis of factors influencing pediatric malaria in Nigeria. Conclusions: This study will provide robust data on pediatric malaria and associated factors in Nigeria. The findings from this study will inform the country’s policy and public health approach as the nation strives to eliminate malaria in line with the WHO’s goals. PROSPERO Registration Number: CRD420251163322.
- 13 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0336091
Open AccessBurden, risk factors, and clinical outcomes of pediatric malaria in Nigeria: A systematic review and meta-analysis protocol
Background: Nigeria ranks number one globally in malaria burden, with the exact burden, especially for hospitalization, unknown. This systematic review and meta-analysis will pool laboratory-confirmed pediatric malaria data across Nigeria using standardized World Health Organization (WHO) case definitions and random-effects modeling to generate precise national and subgroup-specific estimates of prevalence, associated factors, and outcomes, thereby addressing a critical evidence gap. Methods and analysis: A comprehensive search strategy using MeSH terms, text words, and entry terms will be applied across six databases: PubMed, Embase, EBSCOhost, Google Scholar, Web of Science, and Scopus. Eligible studies will be observational and interventional studies, without language restriction, from inception through June 30, 2025. Non-English studies will be translated using professional translation tools [Google Translate (academic mode) and Microsoft Translator] and verified by native speakers. The primary outcome is the pooled prevalence of pediatric malaria [overall, severe malaria vs. uncomplicated]. Secondary outcomes include factors influencing clinical presentation and outcomes, as well as the effects of moderators such as age, sex, socioeconomic status, and geographic location. Data extraction will capture study characteristics, participant demographics, and outcome measures. Methodological, clinical, and statistical heterogeneity will be assessed. Risk of bias will be assessed using the Newcastle-Ottawa Scale (NOS) adapted for observational studies, and the Cochrane Risk of Bias tool (RoB 2.0) for interventional studies. Publication bias will be examined using funnel plots and Egger’s regression. Pooled estimates will be reported with 95% confidence intervals. This will summarize the data on pediatric malaria in Nigeria. Using the random-effects models, the pooled prevalence, along with the 95% CI and the I 2 for the test of heterogeneity, will be reported. We will report the meta-regression analysis of factors influencing pediatric malaria in Nigeria. Conclusions: This study will provide robust data on pediatric malaria and associated factors in Nigeria. The findings from this study will inform the country’s policy and public health approach as the nation strives to eliminate malaria in line with the WHO’s goals. PROSPERO Registration Number: CRD420251163322.
- Open Access
- 14 February 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Agreement and reliability of global rating versus checklist scores in a high-stakes undergraduate OSCE in Rwanda
Despite the objective structured clinical examinations (OSCE) being widely used in the assessment of clinical competency, the optimal scoring systems remai
- 14 February 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessAgreement and reliability of global rating versus checklist scores in a high-stakes undergraduate OSCE in Rwanda
Despite the objective structured clinical examinations (OSCE) being widely used in the assessment of clinical competency, the optimal scoring systems remai
- Open Access
- 24 December 2025
- Published by Springer Nature in Systematic Reviews
- Vol. 15 (1)
Prevalence of sickle cell disease and sickle cell traits among children and adolescents in Nigeria: a systematic review and meta-analysis
Sickle cell disease (SCD) is one of the most common genetic disorders in the world, with Nigeria believed to have the highest burden. Despite the high burd
- 24 December 2025
- Published by Springer Nature in Systematic Reviews
- Vol. 15 (1)
Open AccessPrevalence of sickle cell disease and sickle cell traits among children and adolescents in Nigeria: a systematic review and meta-analysis
Sickle cell disease (SCD) is one of the most common genetic disorders in the world, with Nigeria believed to have the highest burden. Despite the high burd
- Open Access
Burden, Risk Factors, and Clinical Outcomes of Pediatric Malaria in Nigeria: A Systematic Review and Meta-Analysis Protocol
Background: Nigeria ranks number one globally in malaria burden, with the exact burden, especially for hospitalization, unknown. This systematic review and meta-analysis intend to fill this gap by pooling the analysis of pediatric malaria and associated factors in Nigeria. Methods and Analysis: A comprehensive search strategy using MeSH terms, text words, and entry terms will be applied to six databases: PubMed, Embase, EBSCO Hosts, Google Scholar, Web of Science, and Scopus. Eligible studies will be observational and published in English from inception till June 30, 2025. The primary outcome is the pooled prevalence of pediatric malaria [overall, severe malaria vs. uncomplicated]. Secondary outcomes include factors influencing clinical presentation, severity, and outcomes, as well as the effects of moderators such as age, sex, socioeconomic status, and geographic location. Data extraction will capture study characteristics, participant demographics, and outcome measures. Methodological, clinical, and statistical heterogeneity will be assessed. Risk of bias will be evaluated using the Newcastle-Ottawa Scale. Publication bias will be examined using funnel plots, Egger’s regression. Pooled estimates will be reported with 95% confidence intervals. This will summarize the data on pediatric malaria in Nigeria. Using the random-effects models, the pooled prevalence along with the 95% CI and the I 2 for the test of heterogeneity will be reported. We will report the meta-regression analysis of factors influencing pediatric malaria in Nigeria. Conclusions: This study will provide robust data on pediatric malaria and associated factors in Nigeria. The findings from this study will inform the country’s policy and public health approach as the nation strives to eliminate malaria in line with the WHO’s goals. PROSPERO Registration Number: CRD420251163322
Open AccessBurden, Risk Factors, and Clinical Outcomes of Pediatric Malaria in Nigeria: A Systematic Review and Meta-Analysis Protocol
Background: Nigeria ranks number one globally in malaria burden, with the exact burden, especially for hospitalization, unknown. This systematic review and meta-analysis intend to fill this gap by pooling the analysis of pediatric malaria and associated factors in Nigeria. Methods and Analysis: A comprehensive search strategy using MeSH terms, text words, and entry terms will be applied to six databases: PubMed, Embase, EBSCO Hosts, Google Scholar, Web of Science, and Scopus. Eligible studies will be observational and published in English from inception till June 30, 2025. The primary outcome is the pooled prevalence of pediatric malaria [overall, severe malaria vs. uncomplicated]. Secondary outcomes include factors influencing clinical presentation, severity, and outcomes, as well as the effects of moderators such as age, sex, socioeconomic status, and geographic location. Data extraction will capture study characteristics, participant demographics, and outcome measures. Methodological, clinical, and statistical heterogeneity will be assessed. Risk of bias will be evaluated using the Newcastle-Ottawa Scale. Publication bias will be examined using funnel plots, Egger’s regression. Pooled estimates will be reported with 95% confidence intervals. This will summarize the data on pediatric malaria in Nigeria. Using the random-effects models, the pooled prevalence along with the 95% CI and the I 2 for the test of heterogeneity will be reported. We will report the meta-regression analysis of factors influencing pediatric malaria in Nigeria. Conclusions: This study will provide robust data on pediatric malaria and associated factors in Nigeria. The findings from this study will inform the country’s policy and public health approach as the nation strives to eliminate malaria in line with the WHO’s goals. PROSPERO Registration Number: CRD420251163322
- Open Access
Factors Associated with Human Papillomavirus Vaccine Uptake Among Undergraduate Students in a Nigerian University: A Cross-Sectional Study
Background: Despite the proven effectiveness of human papillomavirus (HPV) vaccination in the prevention of HPV-related malignancies, vaccine uptake remains low in many low- and middle-income countries, including Nigeria. This study assessed the level of HPV vaccine uptake and associated factors among undergraduate students at a Nigerian university. Methods: A descriptive cross-sectional study was conducted among 410 undergraduates selected through a multi-stage sampling technique between July and September 2023. Data were collected using a structured, self-administered questionnaire and analysed with SPSS version 26. Results: Of the 410 male and female participants, 1.5% (6/410) received the HPV vaccine, all of whom were female (2.8% of the female respondents). Vaccine uptake was associated with knowing where to obtain the vaccine (p<0.001) and sex (p=0.037). Maternal levels of education, knowledge of the HPV vaccine, age, knowledge of HPV, and socioeconomic class were not related to vaccine uptake. Common reasons for non-uptake of the HPV vaccine included lack of awareness (63.2%; 211/334) and not knowing where to obtain the vaccine (19.2%; 64/334). Conclusion: The uptake of the HPV vaccine was very low, with a major barrier to vaccination being a lack of awareness about the vaccine. Contribution: This study provides a need to strengthened collaboration between university authorities and health authorities in raising awareness, improving accessibility, and enhancing the integration of HPV vaccination services within university settings in Nigeria.
Open AccessFactors Associated with Human Papillomavirus Vaccine Uptake Among Undergraduate Students in a Nigerian University: A Cross-Sectional Study
Background: Despite the proven effectiveness of human papillomavirus (HPV) vaccination in the prevention of HPV-related malignancies, vaccine uptake remains low in many low- and middle-income countries, including Nigeria. This study assessed the level of HPV vaccine uptake and associated factors among undergraduate students at a Nigerian university. Methods: A descriptive cross-sectional study was conducted among 410 undergraduates selected through a multi-stage sampling technique between July and September 2023. Data were collected using a structured, self-administered questionnaire and analysed with SPSS version 26. Results: Of the 410 male and female participants, 1.5% (6/410) received the HPV vaccine, all of whom were female (2.8% of the female respondents). Vaccine uptake was associated with knowing where to obtain the vaccine (p<0.001) and sex (p=0.037). Maternal levels of education, knowledge of the HPV vaccine, age, knowledge of HPV, and socioeconomic class were not related to vaccine uptake. Common reasons for non-uptake of the HPV vaccine included lack of awareness (63.2%; 211/334) and not knowing where to obtain the vaccine (19.2%; 64/334). Conclusion: The uptake of the HPV vaccine was very low, with a major barrier to vaccination being a lack of awareness about the vaccine. Contribution: This study provides a need to strengthened collaboration between university authorities and health authorities in raising awareness, improving accessibility, and enhancing the integration of HPV vaccination services within university settings in Nigeria.
- Open Access
- 25 June 2025
- Published by Springer Nature in Research Square
Prevalence of sickle cell disease and sickle cell trait among children and adolescents in Nigeria: A systematic review and meta-analysis
Background Sickle cell disease (SCD) is one of the most common genetic disorders in the world, with Nigeria believed to have the highest burden. Despite the high burden in the country, the true prevalence of SCD and its main driver- the sickle cell trait (SCT)- is unknown, which is important for planning and resource allocation. Hence, we conducted a systematic review and meta-analysis of the prevalence of SCD, SCT, and the associated sociodemographic factors in Nigerian children and adolescents. Methods The search strategy of this study included MeSH terms, keywords, and entry words from the following databases (AJOL, Google Scholar, PubMed, EMBASE, Cochrane Library, Scopus, and Web of Science collections). The inclusion criteria were studies on children and adolescents in Nigeria that reported the prevalence of SCD and/or SCT and were available in English. The quality of the studies was assessed using the National Institutes of Health Quality Assessment Tool. We used a cumulative meta-analysis to estimate the pooled prevalence, regional prevalence, and associated sociodemographic factors. Publication bias was assessed using funnel plots and Egger's test. Results Of the 40,081 articles obtained from the literature search, we included 30 studies comprising 141,793 participants in the final analysis after a stepwise screening. The pooled prevalence of SCD, sickle cell anemia (SCA), and SCT were 3.6%, 2.9%, and 21.8%, respectively. The northwestern geopolitical zone had the highest pooled prevalence of SCD (5.6%) and SCT (26.8%). The southeast region had the lowest pooled prevalence of SCD (1.4%), while the southwestern region had the lowest pooled prevalence of SCT (19.3%). There was no relationship between SCA and sex or socioeconomic status. Conclusion The pooled prevalence of SCD, SCA, and SCT among children and adolescents was high, with the highest burden in the northwestern geopolitical zone in Nigeria. In addition, there was no relationship between the prevalence of SCA, sex, or socioeconomic class. Systematic review registration: PROSPERO ID: CRD42024556354
- 25 June 2025
- Published by Springer Nature in Research Square
Open AccessPrevalence of sickle cell disease and sickle cell trait among children and adolescents in Nigeria: A systematic review and meta-analysis
Background Sickle cell disease (SCD) is one of the most common genetic disorders in the world, with Nigeria believed to have the highest burden. Despite the high burden in the country, the true prevalence of SCD and its main driver- the sickle cell trait (SCT)- is unknown, which is important for planning and resource allocation. Hence, we conducted a systematic review and meta-analysis of the prevalence of SCD, SCT, and the associated sociodemographic factors in Nigerian children and adolescents. Methods The search strategy of this study included MeSH terms, keywords, and entry words from the following databases (AJOL, Google Scholar, PubMed, EMBASE, Cochrane Library, Scopus, and Web of Science collections). The inclusion criteria were studies on children and adolescents in Nigeria that reported the prevalence of SCD and/or SCT and were available in English. The quality of the studies was assessed using the National Institutes of Health Quality Assessment Tool. We used a cumulative meta-analysis to estimate the pooled prevalence, regional prevalence, and associated sociodemographic factors. Publication bias was assessed using funnel plots and Egger's test. Results Of the 40,081 articles obtained from the literature search, we included 30 studies comprising 141,793 participants in the final analysis after a stepwise screening. The pooled prevalence of SCD, sickle cell anemia (SCA), and SCT were 3.6%, 2.9%, and 21.8%, respectively. The northwestern geopolitical zone had the highest pooled prevalence of SCD (5.6%) and SCT (26.8%). The southeast region had the lowest pooled prevalence of SCD (1.4%), while the southwestern region had the lowest pooled prevalence of SCT (19.3%). There was no relationship between SCA and sex or socioeconomic status. Conclusion The pooled prevalence of SCD, SCA, and SCT among children and adolescents was high, with the highest burden in the northwestern geopolitical zone in Nigeria. In addition, there was no relationship between the prevalence of SCA, sex, or socioeconomic class. Systematic review registration: PROSPERO ID: CRD42024556354
- Open Access
- 9 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0317640
Comparison of WHO laboratory-based and non-laboratory-based CVD risk charts among hypertensive adults attending primary healthcare centers in West Africa sub-region
Background: The World Health Organization (WHO) non-laboratory cardiovascular disease (CVD) risk chart is sub-region-specific and is advocated in resource-constrained settings. However, the extent of agreement with laboratory-based assessment among hypertensive adults attending primary health centers (PHCs) in the West Africa sub-region remains unknown. This study compared 10-year CVD risk among adults with hypertension attending PHCs in Ghana and Nigeria. Materials and methods: This cross-sectional study recruited 319 adults with hypertension at PHCs in Ghana and Nigeria. All participants had their blood pressure, anthropometrics, fasting blood sugar, and fasting cholesterol measured following standard procedures. WHO laboratory and non-laboratory CVD risks were assessed and compared using Kappa statistics, correlation, and Bland-Altman Plot, Results: The median (interquartile range) for laboratory-based and non-laboratory-based CVD risk scores were comparable [7.0 (4.0 11.0) vs. 7.0 (4.0 to 11.0), p = 0.914]. Of the 319 participants, laboratory-based assessment classified 214 (67.1%) as low risk, while 210 (65.8%) were classified as low risk using the non-laboratory method. Eleven (3.4%) and 14 (4.4%) participants were classified as high-risk using laboratory- and non-laboratory-based methods, respectively. Overall, there was a very good positive correlation between the CVD risk assessment methods (r = 0.948, p<0.001). For all participants combined, there was substantial agreement (Kappa statistics), with K = 0.766. Bland-Altman showed a mean bias of 0.15 (SD = 1.74) in favor of non-laboratory-based assessment of CVD with an upper limit of 3.57 and a lower limit of –3.26. Conclusion: There was substantial agreement between laboratory- and non-laboratory-based WHO CVD risk charts in this study. In low-resource settings, such as Ghana and Nigeria, the WHO non-laboratory CVD risk prediction model offers a huge opportunity for primary CVD prevention in adults with hypertension.
- 9 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0317640
Open AccessComparison of WHO laboratory-based and non-laboratory-based CVD risk charts among hypertensive adults attending primary healthcare centers in West Africa sub-region
Background: The World Health Organization (WHO) non-laboratory cardiovascular disease (CVD) risk chart is sub-region-specific and is advocated in resource-constrained settings. However, the extent of agreement with laboratory-based assessment among hypertensive adults attending primary health centers (PHCs) in the West Africa sub-region remains unknown. This study compared 10-year CVD risk among adults with hypertension attending PHCs in Ghana and Nigeria. Materials and methods: This cross-sectional study recruited 319 adults with hypertension at PHCs in Ghana and Nigeria. All participants had their blood pressure, anthropometrics, fasting blood sugar, and fasting cholesterol measured following standard procedures. WHO laboratory and non-laboratory CVD risks were assessed and compared using Kappa statistics, correlation, and Bland-Altman Plot, Results: The median (interquartile range) for laboratory-based and non-laboratory-based CVD risk scores were comparable [7.0 (4.0 11.0) vs. 7.0 (4.0 to 11.0), p = 0.914]. Of the 319 participants, laboratory-based assessment classified 214 (67.1%) as low risk, while 210 (65.8%) were classified as low risk using the non-laboratory method. Eleven (3.4%) and 14 (4.4%) participants were classified as high-risk using laboratory- and non-laboratory-based methods, respectively. Overall, there was a very good positive correlation between the CVD risk assessment methods (r = 0.948, p<0.001). For all participants combined, there was substantial agreement (Kappa statistics), with K = 0.766. Bland-Altman showed a mean bias of 0.15 (SD = 1.74) in favor of non-laboratory-based assessment of CVD with an upper limit of 3.57 and a lower limit of –3.26. Conclusion: There was substantial agreement between laboratory- and non-laboratory-based WHO CVD risk charts in this study. In low-resource settings, such as Ghana and Nigeria, the WHO non-laboratory CVD risk prediction model offers a huge opportunity for primary CVD prevention in adults with hypertension.
- Open Access
- 18 April 2025
- Published by Springer Nature in Malaria Journal
- Vol. 24 (1) , 1-9
Pre-referral injectable artesunate and outcomes of childhood severe malaria at a secondary health facility in North-central Nigeria: a cross-sectional study
The use of pre-referral injectable artesunate is among the strategies adopted to improve the outcome of childhood severe malaria in Nigeria. However, the extent of its implementation and impact on outcomes remain unknown. This study assessed the pre-referral treatment with injectable artesunate for severe malaria, associated factors, and hospitalisation outcomes (discharge or death) among a cohort of children managed at a secondary health facility in Nigeria. This cross-sectional study included children diagnosed with severe malaria admitted to a secondary health facility in Nigeria. Data on pre-referral treatment with injectable artesunate and other medications, demographics, clinical features, and outcomes among children were prospectively gathered and analysed them using SPSS. Of the 137 children recruited, 7(6.3%) received pre-referral injectable artesunate; other medications received included antipyretics (53;47.3%), antibiotics (16;14.3%), artemisinin-based combination therapy (14;12.5%), and supplements (11;9.8%). Pre-referral injectable artesunate treatment was not associated with age, sex, and socioeconomic status (p > 0.05), and most of the clinical features except impaired consciousness with an adjusted odds ratio of 17.876 (95% CI 2.050 to 155.883). Of the 137 children, two deaths occurred, with a crude mortality rate of 1.5% (95% CI 0.04–5.2%). Pre-referral injectable artesunate treatment was not associated with hospitalisation durations and outcomes (death or discharge). This study showed a very low uptake of pre-referral injectable artesunate among children with severe malaria, and the presence of impaired consciousness increased the odds of a child receiving injectable artesunate. In addition, most children with severe malaria had received pre-hospitalisation medications that were mostly inappropriate.
- 18 April 2025
- Published by Springer Nature in Malaria Journal
- Vol. 24 (1) , 1-9
Open AccessPre-referral injectable artesunate and outcomes of childhood severe malaria at a secondary health facility in North-central Nigeria: a cross-sectional study
The use of pre-referral injectable artesunate is among the strategies adopted to improve the outcome of childhood severe malaria in Nigeria. However, the extent of its implementation and impact on outcomes remain unknown. This study assessed the pre-referral treatment with injectable artesunate for severe malaria, associated factors, and hospitalisation outcomes (discharge or death) among a cohort of children managed at a secondary health facility in Nigeria. This cross-sectional study included children diagnosed with severe malaria admitted to a secondary health facility in Nigeria. Data on pre-referral treatment with injectable artesunate and other medications, demographics, clinical features, and outcomes among children were prospectively gathered and analysed them using SPSS. Of the 137 children recruited, 7(6.3%) received pre-referral injectable artesunate; other medications received included antipyretics (53;47.3%), antibiotics (16;14.3%), artemisinin-based combination therapy (14;12.5%), and supplements (11;9.8%). Pre-referral injectable artesunate treatment was not associated with age, sex, and socioeconomic status (p > 0.05), and most of the clinical features except impaired consciousness with an adjusted odds ratio of 17.876 (95% CI 2.050 to 155.883). Of the 137 children, two deaths occurred, with a crude mortality rate of 1.5% (95% CI 0.04–5.2%). Pre-referral injectable artesunate treatment was not associated with hospitalisation durations and outcomes (death or discharge). This study showed a very low uptake of pre-referral injectable artesunate among children with severe malaria, and the presence of impaired consciousness increased the odds of a child receiving injectable artesunate. In addition, most children with severe malaria had received pre-hospitalisation medications that were mostly inappropriate.
- Open Access
- 23 February 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2465817
Acute kidney injury in hospitalized children with diphtheria in northwestern Nigeria: incidence and hospitalization outcomes
Despite the kidney being affected by diphtheria exotoxin, the extent of acute kidney injury (AKI) and its possible impact on outcomes remain unknown. This study examined the incidence, risk factors, and outcomes of AKI in children with diphtheria. This was a prospective cohort study of confirmed diphtheria managed from July 1, 2023, to April 30, 2024, at a health facility in Nigeria. We obtained data on clinical and laboratory features and treatments received. AKI was defined using Kidney Disease: Improving Global Outcomes (KDIGO) criteria. We included 237 children with a median [interquartile range] age of 7.0 [4-10] years. Using KDIGO, 139 (58.6%) had AKI [stage 1:88 (37.1%); stage 2: 18 (7.6%); and stage 3: 33 (13.9%)]. Variables associated with AKI included age, sore throat, inability to swallow, difficulty breathing, nasal blockade, hypoxemia, nasal discharge, pallor, abnormal chest findings, hospitalization duration, vaccination status, white blood cells, lymphocytes, platelets, serum bicarbonate, sodium and potassium, and treatments received, p < 0.05. On multivariable logistic regression, predictors of AKI included age ≤ 60 months [AOR 2.75, 95% CI 1.27-5.95], dexamethasone [AOR 2.57, 95% CI 1.11-4.60], oxygen therapy [4.85, 95% CI 1.24-18.99], and ibuprofen [AOR 2.74, 95 CI% 1.16-6.44]. Mortality rate was 24.5% (58/237) and 33.1% (46/139) in AKI. The odds of deaths with AKI were 3.56 (95% CI 1.76-7.14). There is a high incidence of AKI among children with diphtheria and increased odds of death. Factors that predicted AKI included younger age, oxygen therapy, and medications (ibuprofen and dexamethasone).
- 23 February 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2465817
Open AccessAcute kidney injury in hospitalized children with diphtheria in northwestern Nigeria: incidence and hospitalization outcomes
Despite the kidney being affected by diphtheria exotoxin, the extent of acute kidney injury (AKI) and its possible impact on outcomes remain unknown. This study examined the incidence, risk factors, and outcomes of AKI in children with diphtheria. This was a prospective cohort study of confirmed diphtheria managed from July 1, 2023, to April 30, 2024, at a health facility in Nigeria. We obtained data on clinical and laboratory features and treatments received. AKI was defined using Kidney Disease: Improving Global Outcomes (KDIGO) criteria. We included 237 children with a median [interquartile range] age of 7.0 [4-10] years. Using KDIGO, 139 (58.6%) had AKI [stage 1:88 (37.1%); stage 2: 18 (7.6%); and stage 3: 33 (13.9%)]. Variables associated with AKI included age, sore throat, inability to swallow, difficulty breathing, nasal blockade, hypoxemia, nasal discharge, pallor, abnormal chest findings, hospitalization duration, vaccination status, white blood cells, lymphocytes, platelets, serum bicarbonate, sodium and potassium, and treatments received, p < 0.05. On multivariable logistic regression, predictors of AKI included age ≤ 60 months [AOR 2.75, 95% CI 1.27-5.95], dexamethasone [AOR 2.57, 95% CI 1.11-4.60], oxygen therapy [4.85, 95% CI 1.24-18.99], and ibuprofen [AOR 2.74, 95 CI% 1.16-6.44]. Mortality rate was 24.5% (58/237) and 33.1% (46/139) in AKI. The odds of deaths with AKI were 3.56 (95% CI 1.76-7.14). There is a high incidence of AKI among children with diphtheria and increased odds of death. Factors that predicted AKI included younger age, oxygen therapy, and medications (ibuprofen and dexamethasone).